D-Index & Metrics Best Publications

D-Index & Metrics

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Microbiology D-index 82 Citations 23,541 362 World Ranking 278 National Ranking 7
Medicine D-index 94 Citations 32,108 528 World Ranking 4901 National Ranking 65

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Cancer
  • Gene

His primary scientific interests are in Immunophenotyping, Immunology, Pathology, Internal medicine and Bone marrow. His studies in Immunophenotyping integrate themes in fields like Myeloid, Leukemia, Antibody and Monoclonal. His Pathology research is multidisciplinary, incorporating elements of Flow cytometry, Multiple myeloma and CD117.

The various areas that he examines in his Flow cytometry study include Biological system and Antigen. Alberto Orfao interconnects Gastroenterology and Oncology in the investigation of issues within Internal medicine. His Bone marrow course of study focuses on CD34 and Cancer research.

His most cited work include:

  • A global reference for human genetic variation. (7825 citations)
  • International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma (828 citations)
  • A global reference for human genetic variation (539 citations)

What are the main themes of his work throughout his whole career to date?

Alberto Orfao spends much of his time researching Immunology, Pathology, Internal medicine, Immunophenotyping and Bone marrow. His Pathology research is multidisciplinary, incorporating perspectives in Fluorescence in situ hybridization, Flow cytometry and Cytogenetics. His Flow cytometry research integrates issues from Antibody and B cell.

His study focuses on the intersection of Internal medicine and fields such as Oncology with connections in the field of Disease. His research integrates issues of Leukemia, CD5, CD19 and CD38 in his study of Immunophenotyping. He studied Bone marrow and Haematopoiesis that intersect with Progenitor cell.

He most often published in these fields:

  • Immunology (38.94%)
  • Pathology (28.59%)
  • Internal medicine (29.02%)

What were the highlights of his more recent work (between 2016-2021)?

  • Internal medicine (29.02%)
  • Multiple myeloma (18.25%)
  • Flow cytometry (24.14%)

In recent papers he was focusing on the following fields of study:

His main research concerns Internal medicine, Multiple myeloma, Flow cytometry, Minimal residual disease and Oncology. His work on Disease, Hematopoietic stem cell transplantation and Hematology as part of general Internal medicine study is frequently linked to In patient, therefore connecting diverse disciplines of science. The Multiple myeloma study combines topics in areas such as Monoclonal gammopathy of undetermined significance, Clinical trial, Circulating tumor cell, Clinical significance and Bone marrow.

Alberto Orfao combines subjects such as Myeloid and Pathology with his study of Flow cytometry. He works mostly in the field of Minimal residual disease, limiting it down to topics relating to Acute lymphocytic leukemia and, in certain cases, Vincristine. To a larger extent, Alberto Orfao studies Immunology with the aim of understanding Immunophenotyping.

Between 2016 and 2021, his most popular works were:

  • Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition) (345 citations)
  • Next Generation Flow for highly sensitive and standardized detection of minimal residual disease in multiple myeloma (231 citations)
  • Standardized flow cytometry for highly sensitive MRD measurements in B-cell acute lymphoblastic leukemia (153 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Cancer
  • Gene

Alberto Orfao mainly investigates Flow cytometry, EuroFlow, Internal medicine, Immunophenotyping and Multiple myeloma. His study in Flow cytometry is interdisciplinary in nature, drawing from both Data science and Pathology. His work on Case-control study as part of general Pathology research is frequently linked to Flow, thereby connecting diverse disciplines of science.

His biological study spans a wide range of topics, including Gastroenterology and Oncology. The subject of his Immunophenotyping research is within the realm of Immunology. His Multiple myeloma study integrates concerns from other disciplines, such as Genetics, Clinical trial, Breakpoint, Minimal residual disease and Peripheral blood.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

A global reference for human genetic variation.

Adam Auton;Gonçalo R. Abecasis;David M. Altshuler;Richard M. Durbin.
Nature (2015)

6262 Citations

A global reference for human genetic variation

Adam Auton;Gonçalo R. Abecasis;David M. Altshuler;Richard M. Durbin.
PMC (2015)

1332 Citations

International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma

Shaji Kumar;Bruno Paiva;Kenneth C. Anderson;Brian Durie.
Lancet Oncology (2016)

1131 Citations

EuroFlow antibody panels for standardized n-dimensional flow cytometric immunophenotyping of normal, reactive and malignant leukocytes.

J J M van Dongen;L Lhermitte;S Böttcher;J Almeida.
Leukemia (2012)

728 Citations

Definitions and standards in the diagnosis and treatment of the myelodysplastic syndromes: Consensus statements and report from a working conference

Peter Valent;Hans-Peter Horny;John M. Bennett;Christa Fonatsch.
Leukemia Research (2007)

673 Citations

New criteria to identify risk of progression in monoclonal gammopathy of uncertain significance and smoldering multiple myeloma based on multiparameter flow cytometry analysis of bone marrow plasma cells

Ernesto Pérez-Persona;María-Belén Vidriales;Gema Mateo;Ramón García-Sanz.
Blood (2007)

540 Citations

Report of the European Myeloma Network on multiparametric flow cytometry in multiple myeloma and related disorders

Andy C Rawstron;Alberto Orfao;Meral Beksac;Ludmila Bezdickova.
Haematologica (2008)

536 Citations

EuroFlow standardization of flow cytometer instrument settings and immunophenotyping protocols

T Kalina;J Flores-Montero;V H J van der Velden;M Martin-Ayuso.
Leukemia (2012)

536 Citations

KIT mutation in mast cells and other bone marrow hematopoietic cell lineages in systemic mast cell disorders: a prospective study of the Spanish Network on Mastocytosis (REMA) in a series of 113 patients.

Andres C Garcia-Montero;Maria Jara-Acevedo;Cristina Teodosio;Maria Luz Sanchez.
Blood (2006)

522 Citations

Early immunophenotypical evaluation of minimal residual disease in acute myeloid leukemia identifies different patient risk groups and may contribute to postinduction treatment stratification.

Jesús F. San Miguel;Marı́a B. Vidriales;Consuelo López-Berges;Joaquı́n Dı́az-Mediavilla.
Blood (2001)

448 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Alberto Orfao

Peter Valent

Peter Valent

Medical University of Vienna

Publications: 241

Shaji Kumar

Shaji Kumar

Mayo Clinic

Publications: 111

Kari Stefansson

Kari Stefansson

deCODE Genetics (Iceland)

Publications: 101

Benjamin M. Neale

Benjamin M. Neale

Harvard University

Publications: 99

Ola Landgren

Ola Landgren

University of Miami

Publications: 98

Cem Akin

Cem Akin

University of Michigan–Ann Arbor

Publications: 89

Ramón García-Sanz

Ramón García-Sanz

University of Salamanca

Publications: 85

Ole A. Andreassen

Ole A. Andreassen

Oslo University Hospital

Publications: 81

Morie A. Gertz

Morie A. Gertz

Mayo Clinic

Publications: 80

Olivier Hermine

Olivier Hermine

Université Paris Cité

Publications: 78

Jesús F. San Miguel

Jesús F. San Miguel

University of Navarra

Publications: 77

Angela Dispenzieri

Angela Dispenzieri

Mayo Clinic

Publications: 76

Maria-Victoria Mateos

Maria-Victoria Mateos

University of Salamanca

Publications: 75

Joel Gelernter

Joel Gelernter

Yale University

Publications: 74

Isidro Sánchez-García

Isidro Sánchez-García

University of Salamanca

Publications: 73

S. Vincent Rajkumar

S. Vincent Rajkumar

Mayo Clinic

Publications: 71

Something went wrong. Please try again later.